PhRMA policy VP
Wendy Krasner named Pharmaceutical Research & Manufacturers of America's deputy VP-policy, where she will head new public programs unit of the association's Policy & Research Division. Krasner joins from the D.C. law firm McDermott, Will & Emery, where she was a partner and co-chaired the managed care practice; before that she was an HHS attorney. She will report to Senior VP Rick Smith, who recently gained responsibility for strategic communications in addition to his previous role as policy head (1"The Pink Sheet" April 14, p. 21)...
You may also be interested in...
PhRMA is combining its policy and communications efforts under Senior VP Richard Smith
Vacancies Reform Act requires individual in an acting position to step down in order to be nominated to the permanent post but there are exceptions. Andrew von Eschenbach retained acting title during his nomination in 2006.
To help with the transition to Biden’s COVID-19 response, Woodcock will retain some therapeutic development duties in the program the Trump administration had called Operation Warp Speed.